| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,980 | 13,940 | 15,295 | 17,568 | | Cost of Revenue | 11,225 | 11,593 | 12,506 | 13,472 | | | Gross Profit | 3,755 | 2,347 | 2,789 | 4,096 | | | Operating Expenses | | Research Development | 954 | 990 | 995 | 966 | | Selling General and Administrative | 2,230 | 2,453 | 2,603 | 2,570 | | Non Recurring | 86 | 15,986 |
-
| (157) | | Others | 167 | 258 | 255 | 255 | | | | Total Operating Expenses | 3,437 | 19,687 |
-
| 3,634 | | | | Operating Income or Loss | 404 | (17,340) | (1,064) | 462 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 121 | (211) | 19 | (12) | | Earnings Before Interest And Taxes | 439 | (17,551) | (1,045) | 450 | | Interest Expense | 27 | 20 | 15 | 45 | | Income Before Tax | 412 | (17,571) | (1,060) | 405 | | Income Tax Expense | 133 | (5,456) | (330) | 125 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 279 | (12,115) | (730) | 280 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 279 | (12,115) | (730) | 280 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $279 | ($12,115) | ($730) | $280 |
|
0.51% Nasdaq 0.00%
Income Statement
